NYSE Arca · PJP

Invesco Pharmaceuticals ETF (PJP)

$127.11+0.23%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$127.11▲ 39.42% in range
Sep 29, 2025Low $91.17 · High $131.64Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

Invesco Pharmaceuticals ETF closed at $127.11 on Sep 28, up 0.23%, 3.4% below its 52-week closing high. Volume of 16.9K shares was 0.43× its 20-day average (below normal).

Split-adjusted performance: -1.3% over one month, +27.4% over six months, +40.9% over one year.

Short interest was 7.6K shares at the Sep 15 settlement, down 73.5% from the prior report (1.0 days to cover).

Market cap$569.5M4.5M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield0.95%$0.3014 last paid
52-week range90.21 – 131.64−3.4% from high
Volume16.9K0.43× 20-day avg
Volatility · 60d16.8%Annualised
Short % of float—1.0 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W +0.5%1M −1.3%3M +7.2%6M +27.4%YTD +21.6%1Y +40.9%3Y +72.5%5Y +63.6%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short7.6K−73.5% vs prior
Days to cover1.0Settled Sep 15
% of float—
Short vol. 10d71.6%of daily volume

Quick answers

What is PJP's market cap?
$569.46M, based on the Sep 28 close of $127.11.
Does Invesco Pharmaceuticals ETF pay a dividend?
Yes. The latest regular dividend was $0.3014 per share (ex-date Sep 21), an annualised yield of 0.95%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology